These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36875071)

  • 1. Lung T cell response in COVID-19.
    Shakiba MH; Gemünd I; Beyer M; Bonaguro L
    Front Immunol; 2023; 14():1108716. PubMed ID: 36875071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 activates lung epithelial cell proinflammatory signaling and leads to immune dysregulation in COVID-19 patients.
    Chen H; Liu W; Wang Y; Liu D; Zhao L; Yu J
    EBioMedicine; 2021 Aug; 70():103500. PubMed ID: 34311326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recovery scenario and immunity in COVID-19 disease: A new strategy to predict the potential of reinfection.
    Khoshkam Z; Aftabi Y; Stenvinkel P; Paige Lawrence B; Rezaei MH; Ichihara G; Fereidouni S
    J Adv Res; 2021 Jul; 31():49-60. PubMed ID: 33520309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profiling of T Cell Repertoire in SARS-CoV-2-Infected COVID-19 Patients Between Mild Disease and Pneumonia.
    Chang CM; Feng PH; Wu TH; Alachkar H; Lee KY; Chang WC
    J Clin Immunol; 2021 Aug; 41(6):1131-1145. PubMed ID: 33950324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell responses and therapies against SARS-CoV-2 infection.
    Toor SM; Saleh R; Sasidharan Nair V; Taha RZ; Elkord E
    Immunology; 2021 Jan; 162(1):30-43. PubMed ID: 32935333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Robust Virus-Specific Adaptive Immunity in COVID-19 Patients with SARS-CoV-2 Δ382 Variant Infection.
    Fong SW; Yeo NK; Chan YH; Goh YS; Amrun SN; Ang N; Rajapakse MP; Lum J; Foo S; Lee CY; Carissimo G; Chee RS; Torres-Ruesta A; Tay MZ; Chang ZW; Poh CM; Young BE; Tambyah PA; Kalimuddin S; Leo YS; Lye DC; Lee B; Biswas S; Howland SW; Renia L; Ng LFP
    J Clin Immunol; 2022 Feb; 42(2):214-229. PubMed ID: 34716845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Nasal and Lung Tissues Infected
    Alfi O; Yakirevitch A; Wald O; Wandel O; Izhar U; Oiknine-Djian E; Nevo Y; Elgavish S; Dagan E; Madgar O; Feinmesser G; Pikarsky E; Bronstein M; Vorontsov O; Jonas W; Ives J; Walter J; Zakay-Rones Z; Oberbaum M; Panet A; Wolf DG
    J Virol; 2021 Jun; 95(14):e0013021. PubMed ID: 33893170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status.
    Neidleman J; Luo X; McGregor M; Xie G; Murray V; Greene WC; Lee SA; Roan NR
    Elife; 2021 Oct; 10():. PubMed ID: 34636722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innate Immune Signaling and Proteolytic Pathways in the Resolution or Exacerbation of SARS-CoV-2 in Covid-19: Key Therapeutic Targets?
    Sallenave JM; Guillot L
    Front Immunol; 2020; 11():1229. PubMed ID: 32574272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past.
    Shah VK; Firmal P; Alam A; Ganguly D; Chattopadhyay S
    Front Immunol; 2020; 11():1949. PubMed ID: 32849654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer cells and unconventional T cells in COVID-19.
    Björkström NK; Ponzetta A
    Curr Opin Virol; 2021 Aug; 49():176-182. PubMed ID: 34217135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large-Scale Structure-Based Screening of Potential T Cell Cross-Reactivities Involving Peptide-Targets From BCG Vaccine and SARS-CoV-2.
    Tarabini RF; Rigo MM; Faustino Fonseca A; Rubin F; Bellé R; Kavraki LE; Ferreto TC; Amaral Antunes D; de Souza APD
    Front Immunol; 2021; 12():812176. PubMed ID: 35095907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed severe cytokine storm and immune cell infiltration in SARS-CoV-2-infected aged Chinese rhesus macaques.
    Song TZ; Zheng HY; Han JB; Jin L; Yang X; Liu FL; Luo RH; Tian RR; Cai HR; Feng XL; Liu C; Li MH; Zheng YT
    Zool Res; 2020 Sep; 41(5):503-516. PubMed ID: 32772513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeated Exposure to Subinfectious Doses of SARS-CoV-2 May Promote T Cell Immunity and Protection against Severe COVID-19.
    De Angelis ML; Francescangeli F; Rossi R; Giuliani A; De Maria R; Zeuner A
    Viruses; 2021 May; 13(6):. PubMed ID: 34067349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baricitinib treatment resolves lower-airway macrophage inflammation and neutrophil recruitment in SARS-CoV-2-infected rhesus macaques.
    Hoang TN; Pino M; Boddapati AK; Viox EG; Starke CE; Upadhyay AA; Gumber S; Nekorchuk M; Busman-Sahay K; Strongin Z; Harper JL; Tharp GK; Pellegrini KL; Kirejczyk S; Zandi K; Tao S; Horton TR; Beagle EN; Mahar EA; Lee MYH; Cohen J; Jean SM; Wood JS; Connor-Stroud F; Stammen RL; Delmas OM; Wang S; Cooney KA; Sayegh MN; Wang L; Filev PD; Weiskopf D; Silvestri G; Waggoner J; Piantadosi A; Kasturi SP; Al-Shakhshir H; Ribeiro SP; Sekaly RP; Levit RD; Estes JD; Vanderford TH; Schinazi RF; Bosinger SE; Paiardini M
    Cell; 2021 Jan; 184(2):460-475.e21. PubMed ID: 33278358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immune response to SARS-CoV-2 and COVID-19 immunopathology - Current perspectives.
    Boechat JL; Chora I; Morais A; Delgado L
    Pulmonology; 2021; 27(5):423-437. PubMed ID: 33867315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiology of acute respiratory syndrome coronavirus 2 infection: a systematic literature review to inform EULAR points to consider.
    Najm A; Alunno A; Mariette X; Terrier B; De Marco G; Emmel J; Mason L; McGonagle DG; Machado PM
    RMD Open; 2021 Feb; 7(1):. PubMed ID: 33574116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An
    Erasmus JH; Khandhar AP; O'Connor MA; Walls AC; Hemann EA; Murapa P; Archer J; Leventhal S; Fuller JT; Lewis TB; Draves KE; Randall S; Guerriero KA; Duthie MS; Carter D; Reed SG; Hawman DW; Feldmann H; Gale M; Veesler D; Berglund P; Fuller DH
    Sci Transl Med; 2020 Aug; 12(555):. PubMed ID: 32690628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19.
    Szabo PA; Dogra P; Gray JI; Wells SB; Connors TJ; Weisberg SP; Krupska I; Matsumoto R; Poon MML; Idzikowski E; Morris SE; Pasin C; Yates AJ; Ku A; Chait M; Davis-Porada J; Guo XV; Zhou J; Steinle M; Mackay S; Saqi A; Baldwin MR; Sims PA; Farber DL
    Immunity; 2021 Apr; 54(4):797-814.e6. PubMed ID: 33765436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Broncho-alveolar inflammation in COVID-19 patients: a correlation with clinical outcome.
    Pandolfi L; Fossali T; Frangipane V; Bozzini S; Morosini M; D'Amato M; Lettieri S; Urtis M; Di Toro A; Saracino L; Percivalle E; Tomaselli S; Cavagna L; Cova E; Mojoli F; Bergomi P; Ottolina D; Lilleri D; Corsico AG; Arbustini E; Colombo R; Meloni F
    BMC Pulm Med; 2020 Nov; 20(1):301. PubMed ID: 33198751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.